Search results for "Cyclin-Dependent Kinase Inhibitor p57"

showing 1 items of 1 documents

Beckwith–Wiedemann syndrome: multiple molecular mechanisms

2006

Beckwith–Wiedemann syndrome (BWS) is a congenital overgrowth condition with an increased risk of developing embryonic tumours, such as Wilms' tumour. The cardinal features are abdominal wall defects, macroglossia and gigantism. BWS is generally sporadic; only 10–15% of cases are familial. A variety of molecular aberrations have been associated with BWS. The only mutations within a gene are loss-of-function mutations in the CDKN1C gene, which codes for an imprinted cell-cycle regulator. CDKN1C mutations appear to be particularly associated with umbilical abnormalities, but not with increased predisposition to Wilms' tumour. In the remaining BWS subgroups, a disturbance of the tight epigeneti…

Beckwith-Wiedemann SyndromeGenotypeTranscription GeneticBeckwith–Wiedemann syndromeBioinformaticsModels BiologicalEpigenesis GeneticGenomic ImprintingGenotypeMacroglossiaAnimalsHumansMedicineEpigeneticsCyclin-Dependent Kinase Inhibitor p57Molecular BiologyModels Geneticbusiness.industryDNA Methylationmedicine.diseasePhenotypeGigantismPhenotypeMutationDNA methylationMolecular Medicinemedicine.symptombusinessGenomic imprintingExpert Reviews in Molecular Medicine
researchProduct